{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:11:05Z","timestamp":1782987065132,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,26]]},"DOI":"10.7759\/cureus.91018","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:44:27Z","timestamp":1756208667000},"source":"Crossref","is-referenced-by-count":2,"title":["Ocular Manifestations of Sickle Cell Disease With an Emphasis on Retinal Involvement"],"prefix":"10.7759","author":[{"given":"Markandeya","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawahar Jyoti","family":"Kuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Gogoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)07330-3","article-title":"Sickle-cell disease","volume":"350","author":"Serjeant GR","year":"1997","unstructured":"Serjeant GR. Sickle-cell disease. Lancet. 1997, 350:725-30. 10.1016\/S0140-6736(97)07330-3","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27492013000500016","article-title":"Sickle cell retinopathy: diagnosis and treatment","volume":"76","author":"Bonanomi MT","year":"2013","unstructured":"Bonanomi MT, Lavezzo MM. Sickle cell retinopathy: diagnosis and treatment. Arq Bras Oftalmol. 2013, 76:320-7. 10.1590\/s0004-27492013000500016","journal-title":"Arq Bras Oftalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(71)90429-6","article-title":"Classification and pathogenesis of proliferative sickle retinopathy","volume":"71","author":"Goldberg MF","year":"1971","unstructured":"Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 1971, 71:649-65. 10.1016\/0002-9394(71)90429-6","journal-title":"Am J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1981.00340080127029","article-title":"Combined sickle cell disease and autoimmune hemolytic anemia","volume":"141","author":"Chaplin H Jr","year":"1981","unstructured":"Chaplin H Jr, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med. 1981, 141:1091-3. 10.1001\/archinte.1981.00340080127029","journal-title":"Arch Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0181-5512(08)74745-4","article-title":"[Screening for sickle cell disease retinopathy in the north of France]","volume":"31","author":"Tran TH","year":"2008","unstructured":"Tran TH, Mekinian A, Godinaud M, Rose C. [Screening for sickle cell disease retinopathy in the north of France]. J Fr Ophtalmol. 2008, 31:987-92. 10.1016\/s0181-5512(08)74745-4","journal-title":"J Fr Ophtalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1179\/146532810X12637745451870","article-title":"Ocular manifestations of sickle cell disease","volume":"30","author":"Fadugbagbe AO","year":"2010","unstructured":"Fadugbagbe AO, Gurgel RQ, Mendon\u00e7a CQ, Cipolotti R, dos Santos AM, Cuevas LE. Ocular manifestations of sickle cell disease. Ann Trop Paediatr. 2010, 30:19-26. 10.1179\/146532810X12637745451870","journal-title":"Ann Trop Paediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.09.025","article-title":"Clinical and ophthalmic factors associated with the severity of sickle cell retinopathy","volume":"197","author":"Duan XJ","year":"2019","unstructured":"Duan XJ, Lanzkron S, Linz MO, Ewing C, Wang J, Scott AW. Clinical and ophthalmic factors associated with the severity of sickle cell retinopathy. Am J Ophthalmol. 2019, 197:105-13. 10.1016\/j.ajo.2018.09.025","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09286586.2020.1801762","article-title":"Ocular manifestations of sickle cell disease in different genotypes","volume":"28","author":"AlRyalat SA","year":"2021","unstructured":"AlRyalat SA, Jaber BA, Alzarea AA, Alzarea AA, Alosaimi WA, Al Saad M. Ocular manifestations of sickle cell disease in different genotypes. Ophthalmic Epidemiol. 2021, 28:185-90. 10.1080\/09286586.2020.1801762","journal-title":"Ophthalmic Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004247","article-title":"Macular neurodegenerative and vascular changes on optical coherence tomographic angiography in sickle cell disease are not related to its ocular and systemic complications","volume":"44","author":"Brandsen RP","year":"2024","unstructured":"Brandsen RP, Biemond BJ, Nasim GZ, Nur E, Schlingemann RO, Diederen RM. Macular neurodegenerative and vascular changes on optical coherence tomographic angiography in sickle cell disease are not related to its ocular and systemic complications. Retina. 2024, 44:2185-95. 10.1097\/IAE.0000000000004247","journal-title":"Retina"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-022-00419-8","article-title":"Risk factors associated with sickle cell retinopathy: findings from the Cooperative Study of Sickle Cell Disease","volume":"8","author":"Nawaiseh M","year":"2022","unstructured":"Nawaiseh M, Roto A, Nawaiseh Y, et al.. Risk factors associated with sickle cell retinopathy: findings from the Cooperative Study of Sickle Cell Disease. Int J Retina Vitreous. 2022, 8:68. 10.1186\/s40942-022-00419-8","journal-title":"Int J Retina Vitreous"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-014-0333-0","article-title":"Ocular manifestations in Egyptian children and young adults with sickle cell disease","volume":"30","author":"El-Ghamrawy MK","year":"2014","unstructured":"El-Ghamrawy MK, El Behairy HF, El Menshawy A, Awad SA, Ismail A, Gabal MS. Ocular manifestations in Egyptian children and young adults with sickle cell disease. Indian J Hematol Blood Transfus. 2014, 30:275-80. 10.1007\/s12288-014-0333-0","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002057","article-title":"Utility of ultra-widefield retinal imaging for the staging and management of sickle cell retinopathy","volume":"39","author":"Han IC","year":"2019","unstructured":"Han IC, Zhang AY, Liu TY, Linz MO, Scott AW. Utility of ultra-widefield retinal imaging for the staging and management of sickle cell retinopathy. Retina. 2019, 39:836-43. 10.1097\/IAE.0000000000002057","journal-title":"Retina"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.08.010","article-title":"Optical coherence tomography angiography and ultra-widefield fluorescein angiography for early detection of adolescent sickle retinopathy","volume":"183","author":"Pahl DA","year":"2017","unstructured":"Pahl DA, Green NS, Bhatia M, et al.. Optical coherence tomography angiography and ultra-widefield fluorescein angiography for early detection of adolescent sickle retinopathy. Am J Ophthalmol. 2017, 183:91-8. 10.1016\/j.ajo.2017.08.010","journal-title":"Am J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000210","article-title":"Optical coherence tomography angiography of sickle cell maculopathy","volume":"9","author":"Sanfilippo CJ","year":"2015","unstructured":"Sanfilippo CJ, Klufas MA, Sarraf D, Tsui I. Optical coherence tomography angiography of sickle cell maculopathy. Retin Cases Brief Rep. 2015, 9:360-2. 10.1097\/ICB.0000000000000210","journal-title":"Retin Cases Brief Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010790.pub3","article-title":"Laser therapy for retinopathy in sickle cell disease","volume":"12","author":"Myint KT","year":"2022","unstructured":"Myint KT, Sahoo S, Thein AW, Moe S, Ni H. Laser therapy for retinopathy in sickle cell disease. Cochrane Database Syst Rev. 2022, 12:CD010790. 10.1002\/14651858.CD010790.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120957615","article-title":"Prevalence of ocular abnormalities in relation to sickle cell disease severity among children in South-western, Nigeria","volume":"31","author":"Oladimeji OI","year":"2021","unstructured":"Oladimeji OI, Adeodu OO, Onakpoya OH, Adegoke SA. Prevalence of ocular abnormalities in relation to sickle cell disease severity among children in South-western, Nigeria. Eur J Ophthalmol. 2021, 31:2659-65. 10.1177\/1120672120957615","journal-title":"Eur J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/2474126417738627","article-title":"Intravitreal bevacizumab for proliferative sickle retinopathy: a case series","volume":"2","author":"Cai CX","year":"2017","unstructured":"Cai CX, Linz MO, Scott AW. Intravitreal bevacizumab for proliferative sickle retinopathy: a case series. J Vitreoretin Dis. 2017, 2:32-8. 10.1177\/2474126417738627","journal-title":"J Vitreoretin Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1988.01060140721042","article-title":"Pars plana vitrectomy in the management of complications of proliferative sickle retinopathy","volume":"106","author":"Pulido JS","year":"1988","unstructured":"Pulido JS, Flynn HW Jr, Clarkson JG, Blankenship GW. Pars plana vitrectomy in the management of complications of proliferative sickle retinopathy. Arch Ophthalmol. 1988, 106:1553-7. 10.1001\/archopht.1988.01060140721042","journal-title":"Arch Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009147","article-title":"Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study","volume":"7","author":"Brandsen RP","year":"2023","unstructured":"Brandsen RP, Diederen RM, Bakhlakh S, Nur E, Schlingemann RO, Biemond BJ. Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study. Blood Adv. 2023, 7:3080-6. 10.1182\/bloodadvances.2022009147","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390351-ocular-manifestations-of-sickle-cell-disease-with-an-emphasis-on-retinal-involvement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:44:27Z","timestamp":1756208667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390351-ocular-manifestations-of-sickle-cell-disease-with-an-emphasis-on-retinal-involvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.91018","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}